Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
- 15 August 2009
- Vol. 393 (1) , 144-150
- https://doi.org/10.1016/j.virol.2009.07.018
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Expression and Purification of a Recombinant Adenovirus Fiber Knob in a Baculovirus SystemIntervirology, 2008
- A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitroImmunology Letters, 2008
- Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infectionVaccine, 2008
- Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles virusesVaccine, 2008
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV InfectionThe Journal of Immunology, 2008
- Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivityBiochemical and Biophysical Research Communications, 2007
- Induction of Specific Immune Responses by Severe Acute Respiratory Syndrome Coronavirus Spike DNA Vaccine with or without Interleukin-2 Immunization Using Different Vaccination Routes in MiceClinical and Vaccine Immunology, 2007
- Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceVaccine, 2007
- Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaquesVaccine, 2007
- Immunization of Mice with a DNA Vaccine Based on Severe Acute Respiratory Syndrome Coronavirus Spike Protein Fragment 1Viral Immunology, 2006